NCT00520949View on ClinicalTrials.gov

Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Treatment of Helicobacter Pylori
Interventions
DRUG

Augmentin (Amoxicillin-clavulanic)

Amoxicillin-clavulanic acid 1 gram b.i.d

DRUG

Furoxone (furazolidone)

furazolidone 200 mg b.i.d

DRUG

Cebes (colloidal bismuth subcitrate)

colloidal bismuth subcitrate 240 mg b.i.d

DRUG

Esso (esomeprazole)

esomeprazole 40 mg b.i.d for 14 days

Trial Locations (1)

74800

Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER

NCT00520949 - Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter